These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30968402)

  • 1. The influence of birth cohort and calendar period on global trends in ovarian cancer incidence.
    Cabasag CJ; Arnold M; Butler J; Inoue M; Trabert B; Webb PM; Bray F; Soerjomataram I
    Int J Cancer; 2020 Feb; 146(3):749-758. PubMed ID: 30968402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis.
    Zhang Y; Luo G; Li M; Guo P; Xiao Y; Ji H; Hao Y
    BMC Cancer; 2019 Oct; 19(1):984. PubMed ID: 31640608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000.
    Bray F; Loos AH; Tognazzo S; La Vecchia C
    Int J Cancer; 2005 Mar; 113(6):977-90. PubMed ID: 15505879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
    dos Santos Silva I; Swerdlow AJ
    Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future.
    Webb PM; Green AC; Jordan SJ
    Cancer Causes Control; 2017 May; 28(5):365-370. PubMed ID: 28233113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age.
    Villard-Mackintosh L; Vessey MP; Jones L
    Br J Obstet Gynaecol; 1989 Jul; 96(7):783-8. PubMed ID: 2788456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use.
    Gnagy S; Ming EE; Devesa SS; Hartge P; Whittemore AS
    Epidemiology; 2000 Mar; 11(2):102-5. PubMed ID: 11021604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The Netherlands.
    Koper NP; Kiemeney LA; Massuger LF; Thomas CM; Schijf CP; Verbeek AL
    Obstet Gynecol; 1996 Sep; 88(3):387-93. PubMed ID: 8752245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.
    Bray F; Dos Santos Silva I; Moller H; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1132-42. PubMed ID: 15894663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth cohort and calendar period trends in breast cancer mortality in the United States and Canada.
    Tarone RE; Chu KC; Gaudette LA
    J Natl Cancer Inst; 1997 Feb; 89(3):251-6. PubMed ID: 9017006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in cancer rates among adults born between 1920 and 1990 in the USA: an analysis of population-based cancer registry data.
    Sung H; Jiang C; Bandi P; Minihan A; Fidler-Benaoudia M; Islami F; Siegel RL; Jemal A
    Lancet Public Health; 2024 Aug; 9(8):e583-e593. PubMed ID: 39095135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976-2005: an age-period-cohort analysis.
    Dhillon PK; Yeole BB; Dikshit R; Kurkure AP; Bray F
    Br J Cancer; 2011 Aug; 105(5):723-30. PubMed ID: 21829198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International patterns and trends in ovarian cancer incidence, overall and by histologic subtype.
    Coburn SB; Bray F; Sherman ME; Trabert B
    Int J Cancer; 2017 Jun; 140(11):2451-2460. PubMed ID: 28257597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007.
    Trabert B; Chen J; Devesa SS; Bray F; McGlynn KA
    Andrology; 2015 Jan; 3(1):4-12. PubMed ID: 25331326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian and endometrial cancers.
    Mant JW; Vessey MP
    Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and ovarian cancer: an update, 1998-2004.
    La Vecchia C
    Eur J Cancer Prev; 2006 Apr; 15(2):117-24. PubMed ID: 16523008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013.
    Lortet-Tieulent J; Ferlay J; Bray F; Jemal A
    J Natl Cancer Inst; 2018 Apr; 110(4):354-361. PubMed ID: 29045681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990-2017.
    Zheng L; Cui C; Shi O; Lu X; Li YK; Wang W; Li Y; Wang Q
    Gynecol Oncol; 2020 Oct; 159(1):239-247. PubMed ID: 32690392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Descriptive epidemiology of ovarian cancer in Europe.
    La Vecchia C; Levi F; Lucchini F; Negri E; Franceschi S
    Gynecol Oncol; 1992 Aug; 46(2):208-15. PubMed ID: 1500024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.